The syringe is filled with AstraZeneca vaccine at the pharmacy.
Christopher Neundorff | Image Alliance | Getty Images
London-Wednesday European drug regulators announced possible links between coronavirus vaccines developed by AstraZeneca Rare blood clotting problems in adults who received shots with Oxford University..
This is done after reviewing all currently available evidence for the very rare cases of abnormal blood clots in some vaccinated people.
Emer Cooke, the secretary-general of the European Medicines Agency, said in a press conference televised that the regulatory safety committee said, “The benefits of the AstraZeneca vaccine in the prevention of Covid-19 are an overall risk of side effects. I confirmed that it would exceed. “
The EMA Safety Commission concluded that “as a result of a very detailed analysis, cases of abnormal blood clotting reported after vaccination with the AstraZeneca vaccine should be listed as possible side effects of the vaccine. “Cook said.
“A plausible explanation for these rare side effects is an immune response to a vaccine similar to that found in patients treated with heparin,” she said, calling it heparin-induced thrombocytopenia. It was.
AstraZeneca’s share price fell about 0.8% during the afternoon trading in London.
Oxford-AstraZeneca shots have been plagued by safety concerns in some European countries in recent weeks pause Vaccine use last month.
EMA Said On March 31, the shot turned out to be safe and effective, but added that the investigation could not be ruled out as a possible causal link between the vaccine and the coagulation event.
World Health Organization, UK drug regulators, and International conference on thrombosis and hemostasis Everyone says that the benefits of managing Oxford-AstraZeneca shots far outweigh the risks.
AstraZeneca has previously stated in a study that the vaccine does not increase the risk of blood clots.
Since then, most countries have resumed the use of shots, but many have suspended vaccinations for certain age groups.
High-ranking European drug regulator Reportedly On Tuesday, he said there was a clear “link” between the Oxford-AstraZeneca vaccine and a very rare blood clot in the brain, although the direct cause is not yet known.
In an interview with the Italian newspaper Il Messaggero, published Tuesday, Marco Cavaleri, chair of the EMA’s vaccine evaluation team, said: I don’t know what causes this reaction. “
The EMA then denied in a statement to Agence France-Presse that it had established some link between the Oxford-AstraZeneca shot and a rare blood clot.
The Medicines and Healthcare Products Regulatory Agency, which has approved the use of the Oxford-AstraZeneca vaccine in the United Kingdom, is examining data following a few reports of serious but rare blood clots in both the United Kingdom and the European continent. , Some of them are deadly.
The Oxford-AstraZeneca Vaccine for Children UK, while drug regulators are investigating the possibility of a link between shots and cases of blood coagulation disorders, especially intravenous thrombosis in the brain known as cerebral sinus thrombosis. The study in was already suspended (CVST) and thrombosis (low levels of platelets that help blood clots).
By March 24, the UK government reported 22 CVSTs out of a total of 18.1 million (two) doses of AstraZeneca vaccine and 8 reports of other thrombotic events with thrombocytopenia. Said there was. Given by that date.
People will wait at the Immunization Center in Cologne, Germany, on April 5, 2021.
Marius Becker | Image Alliance | Getty Images
Prior to Wednesday’s announcement, Adam Finn, a pediatric professor at the University of Bristol in the United Kingdom, said, “We need to know more about the affected people and understand exactly how the disease happened. But many other questions have not been answered at this time. ” ..
“But there are some very clear things. The first is that these cases are actually very rare. The second is that the vaccines available and used in the UK are COVID. Is very effective in preventing this, “Fin said.
“In short, if you are currently being offered a dose of the Oxford-AstraZeneca vaccine, your chances of staying alive will increase if you take the vaccine, otherwise it will decrease.”
— CNBC’s Holly Ellyatt contributed to this report.
EU drug regulators have discovered a possible link between the AstraZeneca Covid vaccine and blood clots
Source link EU drug regulators have discovered a possible link between the AstraZeneca Covid vaccine and blood clots